Picture of Goodrx Holdings logo

GDRX Goodrx Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapHigh Flyer

Annual cashflow statement for Goodrx Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line66-294-25.3-32.8-8.87
Depreciation
Deferred Taxes
Non-Cash Items14.2450168146127
Unusual Items
Other Non-Cash Items
Changes in Working Capital-4.82-32.5-11.8-20.3-21.9
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities83.3131179147138
Capital Expenditures-5.75-35.8-34.5-55.2-55.8
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items-31.3-55.8-144-1550
Acquisition of Business
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities-37.1-91.6-179-210-55.8
Financing Cash Flow Items-2.2115-58.5-20.6-64.1
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-54.8906-30.5-120-167
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-8.55946-30.5-184-84.9